← Back to comparison tool

Noom Med GLP-1 Cost 2026: Microdose vs Brand-Name Pricing Explained

Last verified: May 30, 2026

Two distinct programs at very different price points. The $99/mo Microdose is the realistic self-pay option. The $69/mo brand-name program is a program fee only — medication is on top and needs insurance to make sense.

Self-pay (no insurance)
Microdose GLP-1: $99/mo all-in
├──Program fee: Included
├──Medication: Included
└──Noom app: Included
The microdose is the option that shows in the no-insurance flow on our comparison tool.
With insurance
Brand-name access: $69/mo + medication copay
├──Program fee: $69/mo
├──Medication: Your insurance copay (varies)
└──Noom app: Included
For self-pay users without insurance, this program doesn't pencil out — brand-name retail medication runs $800–$1,300/mo on top of the $69 fee.

How Noom Med's pricing actually works

Noom Med is unique among the providers we track because they offer two completely different programs at different price points. The headline number you see depends entirely on which program you sign up for.

Program 1 — Noom Microdose GLP-1 ($99/mo)

  • Compounded, lower-dose GLP-1 medication.
  • $99/mo is the ALL-IN cost — program fee and medication are bundled.
  • No insurance required.
  • Includes full access to the Noom behavioral health app.
  • FSA/HSA eligible.
  • This is the option that shows in our "No Insurance" comparison flow.

Program 2 — Noom GLP-1 Brand-Name Access ($69/mo + medication)

  • Provides access to brand-name Ozempic and Zepbound.
  • $69/mo is the PROGRAM FEE only — it covers clinician access, the Noom app, and ongoing support.
  • Medication cost is separate and depends on your insurance coverage.
  • If your insurance covers GLP-1s, your copay could be $0–$50/mo on top of the $69 program fee.
  • Without insurance, brand-name medication runs $800–$1,300/mo at retail — making this path impractical for self-pay users.
  • FSA/HSA eligible.

Program 3 — Noom GLP-1 Plus

  • Higher-dose compounded tirzepatide (GLP-1 + GIP dual agonist).
  • Pricing requires completing intake — not publicly listed.
  • FSA/HSA eligible.

The "$69/mo" marketing rate

The $69 headline is the brand-name program fee only. It doesn't include medication. For uninsured shoppers, this program isn't cheaper than self-pay alternatives like Oak ($133–$199/mo all-in) because the medication side adds $800+/mo at retail. The $99 Microdose is the realistic self-pay option from Noom Med.

What's included across all Noom Med plans

  • Full access to the Noom behavioral health app
  • Psychology-based lessons and habit-building curriculum
  • Progress-tracking tools
  • Supportive coaching and community
  • Clinician consultations and prescription management
  • Personalized dosing to minimize side effects

How Noom Med compares

ProviderSelf-pay monthlyInsurance path?App/coaching included?
Noom Med Microdose$99/mo all-inN/AYes (full Noom app)
Oak$133–$199/mo all-inNoNo
Noom Med Brand-Name$69/mo + copayYesYes (full Noom app)
RoEst. $220–$400/moPartialNo

To run every provider against your own insurance + state + condition, use our free comparison tool.

Pricing sources

  • Noom Med official pagenoom.com/med/ — verified May 30, 2026
  • Noom Med FAQ section"How much does weight-loss medication cost with Noom?"
  • Product listingsMicrodose GLP-1 from $99/mo; Brand-name from $69/mo + medication
Compare every GLP-1 provider in one place
Sorted by total monthly cost. Full fee breakdown. Verified status for every brand.
Compare all GLP-1 providers →
Get notified when prices change
We re-verify provider pricing monthly. Drop your email and we'll alert you when this provider's pricing or programs change.
No spam. Unsubscribe anytime.

© 2026 Olson Coaches|About|Privacy Policy|Terms of Use|Contact|Pricing Guides

Guides:Cheapest GLP-1 Without Insurance·Ozempic vs Mounjaro Cost·Self-Pay Options

Tools:Medicare Bridge eligibility checker·Provider legitimacy checker

Medicare:Bridge Program 2026 guide

Affiliate Disclosure: We may earn commissions from partner links.

Sources: TrumpRx.gov, GoodRx, NovoCare, LillyDirect, CMS, KFF, FDA.gov

Impact-Site-Verification: 48834932-8f60-4805-9874-60023e703ddc